tiprankstipranks
China Pharma Holdings (CPHI)
XASE:CPHI
US Market
CPHI
China Pharma Holdings
RESEARCH TOOLSreports

China Pharma Holdings (CPHI) Ratios

275 Followers

China Pharma Holdings Ratios

CPHI's free cash flow for Q4 2025 was $0.12. For the 2025 fiscal year, CPHI's free cash flow was decreased by $ and operating cash flow was $-0.98. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.32 0.32 0.65 0.88 0.47
Quick Ratio
 0.10 0.10 0.20 0.33 0.24
Cash Ratio
 0.05 0.05 0.12 0.21 0.16
Solvency Ratio
 >-0.01 >-0.01 -0.30 -0.04 -0.09
Operating Cash Flow Ratio
 <0.01 <0.01 -0.09 -0.10 -0.03
Short-Term Operating Cash Flow Coverage
 <0.01 <0.01 -0.22 -0.23 -0.05
Net Current Asset Value
$ -5.91T$ -5.91T$ -3.87M$ -3.02M$ -7.53M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 0.24 0.28 0.49
Debt-to-Equity Ratio
 <0.01 <0.01 0.46 0.62 2.04
Debt-to-Capital Ratio
 <0.01 <0.01 0.32 0.38 0.67
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.15 0.16 0.00
Financial Leverage Ratio
 1.36 1.36 1.92 2.21 4.15
Debt Service Coverage Ratio
 >-0.01 >-0.01 -0.85 <0.01 -0.09
Interest Coverage Ratio
 -31.74 -30.27 -29.77 -8.25 -8.17
Debt to Market Cap
 93.33K 35.28K 0.09 0.07 0.03
Interest Debt Per Share
 42.69K 42.69K 0.21 0.47 1.75
Net Debt to EBITDA
 102.33K 107.50K -1.51 380.53 -8.03
Profitability Margins
Gross Profit Margin
-3.18%-3.18%-43.84%-4.01%-6.09%
EBIT Margin
-74.47%-74.45%-101.18%-39.15%-43.66%
EBITDA Margin
-38.19%-36.35%-43.37%0.12%-10.34%
Operating Profit Margin
-78.16%-74.53%-101.32%-39.25%-43.79%
Pretax Profit Margin
-76.91%-76.91%-104.58%-43.91%-49.02%
Net Profit Margin
-76.91%-76.91%-104.58%-43.91%-49.02%
Continuous Operations Profit Margin
-76.91%-76.91%-104.58%-43.91%-49.02%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
98.41%103.21%103.21%111.88%111.94%
Return on Assets (ROA)
>-0.01%>-0.01%-31.81%-18.69%-22.34%
Return on Equity (ROE)
>-0.01%>-0.01%-61.13%-41.30%-92.61%
Return on Capital Employed (ROCE)
>-0.01%>-0.01%-46.49%-28.52%-70.35%
Return on Invested Capital (ROIC)
>-0.01%>-0.01%-38.02%-21.45%-25.71%
Return on Tangible Assets
>-0.01%>-0.01%-60.72%-24.02%-25.51%
Earnings Yield
-120.30%-61.39%-11.64%-4.80%-1.57%
Efficiency Ratios
Receivables Turnover
 14.26 14.26 16.11 9.63 17.45
Payables Turnover
 4.80 4.80 28.94 7.55 12.89
Inventory Turnover
 <0.01 <0.01 2.87 1.95 2.92
Fixed Asset Turnover
 <0.01 <0.01 1.00 1.03 0.84
Asset Turnover
 <0.01 <0.01 0.30 0.43 0.46
Working Capital Turnover Ratio
 >-0.01 >-0.01 -3.52 -1.85 -1.98
Cash Conversion Cycle
 138.40M 138.40M 137.01 176.36 117.74
Days of Sales Outstanding
 25.60 25.60 22.65 37.91 20.92
Days of Inventory Outstanding
 138.40M 138.40M 126.97 186.82 125.14
Days of Payables Outstanding
 76.06 76.06 12.61 48.37 28.32
Operating Cycle
 138.40M 138.40M 149.62 224.74 146.06
Cash Flow Ratios
Operating Cash Flow Per Share
 0.03 0.03 -0.03 -0.07 -0.08
Free Cash Flow Per Share
 0.01 <0.01 -0.04 -0.07 -0.15
CapEx Per Share
 0.02 0.03 0.02 <0.01 0.08
Free Cash Flow to Operating Cash Flow
 0.34 0.07 1.63 1.02 1.98
Dividend Paid and CapEx Coverage Ratio
 1.52 1.08 -1.60 -60.75 -1.02
Capital Expenditure Coverage Ratio
 1.52 1.08 -1.60 -60.75 -1.02
Operating Cash Flow Coverage Ratio
 <0.01 <0.01 -0.13 -0.15 -0.05
Operating Cash Flow to Sales Ratio
 0.04 0.04 -0.10 -0.10 -0.05
Free Cash Flow Yield
2.60%0.21%-1.86%-1.11%-0.32%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.83 -1.63 -8.59 -20.83 -63.51
Price-to-Sales (P/S) Ratio
 0.47 1.25 8.98 9.15 31.14
Price-to-Book (P/B) Ratio
 <0.01 <0.01 5.25 8.60 58.82
Price-to-Free Cash Flow (P/FCF) Ratio
 38.49 471.58 -53.68 -90.17 -310.94
Price-to-Operating Cash Flow Ratio
 17.87 35.02 -87.25 -91.65 -616.12
Price-to-Earnings Growth (PEG) Ratio
 -0.21 >-0.01 1.25 0.24 -0.50
Price-to-Fair Value
 <0.01 <0.01 5.25 8.60 58.82
Enterprise Value Multiple
 102.32K 107.50K -22.23 7.98K -309.25
Enterprise Value
 -161.93B -161.93B 43.65M 67.34M 259.06M
EV to EBITDA
 102.32K 107.50K -22.23 7.98K -309.25
EV to Sales
 -39.07K -39.07K 9.64 9.60 31.97
EV to Free Cash Flow
 -3.18M -14.71M -57.59 -94.68 -319.23
EV to Operating Cash Flow
 -1.09M -1.09M -93.61 -96.24 -632.55
Tangible Book Value Per Share
 -312.17K -312.17K 0.04 0.36 0.40
Shareholders’ Equity Per Share
 5.30M 5.30M 0.44 0.70 0.82
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.97 0.97 0.26 0.66 1.54
Net Income Per Share
 -0.74 -0.74 -0.27 -0.29 -0.76
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.03 1.03 1.03 1.12 1.12
Research & Development to Revenue
 0.07 0.07 0.06 0.03 0.02
SG&A to Revenue
 0.68 0.68 0.51 0.21 0.23
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 <0.01
Income Quality
 -0.05 -0.05 0.10 0.23 0.10
Currency in USD